Trends in use of long-acting reversible contraception during delivery hospitalizations, 2000–2019 - 28/09/22
Plan
M.E.D. had a senior leadership role in the American College of Obstetricians and Gynecologists II’s Safe Motherhood Initiative, which received unrestricted funding from Merck for Mothers. T.W. serves as a consultant on the medical advisory board for Delfina, Inc. The other authors do not report any potential conflict of interest. |
|
The authors report no funding for this study. |
|
This analysis was deemed exempt by the Columbia University Institutional Review Board (AAAE8144). |
Vol 227 - N° 4
P. 659 - octobre 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?